UNSPSC 51284041: Rolitetracycline nitrate anhydrous

This classification denotes a tetracycline antibiotic with the molecular formula C27H33N3O8.HNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 496ESB4HTE, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-n-(1-pyrrolidinylmethyl)-, (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-, mononitrate (salt),, but more generally known as rolitetracycline nitrate anhydrous, which bears US NIH Compound Identifier 5360293.

UNSPSC 51284041 Rolitetracycline nitrate anhydrous is a Commodity code that in recent state and local procurement activity captures pharmaceutical inventory management and emergency medical supply procurement rather than the specific antibiotic compound its name suggests. State and local issuing bodies soliciting under this code include state health departments and county health authorities procuring drugs and medical supplies for public health stockpiles, community health centers, and emergency response programs. The scope of work reflects warehouse distribution of pharmaceuticals through cooperative purchasing consortia and direct competitive bidding for critical medical supplies including antibiotics, opioid antagonists, and drug deactivation systems used in community health and harm-reduction initiatives.

Recent activity appears concentrated in the South and Midwest. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 (solicitation 26482DPHPREPDB53392), sourcing Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets totaling $2,999,999.11 over the initial 12-month term plus two renewal years; Seminole County, Florida issued an IFB (IFB60459723LAS) with a July 26, 2023 deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building. Neither opportunity carried explicit set-aside designations or domestic-product preferences. The code shows limited recent posted activity; the Illinois contract was a completed award rather than an open solicitation, and the Seminole opportunity carried an antiquated deadline relative to today's date, suggesting the code may see infrequent posting or aggregation under broader pharmaceutical procurement codes.